July 2026 in “Vestnik dermatologii i venerologii” This study found that a serum with a minoxidil derivative and high-concentration niacinamide was effective in improving androgenetic alopecia in women, with 65.8% showing clinical recovery after 4 months, and reported good tolerability and increased treatment compliance.
July 2026 in “Vestnik dermatologii i venerologii” Among women with androgenetic alopecia, this study observed that using Jet Peel™ with JetCare® serum led to significant trichoscopic changes, high satisfaction, and good safety after five weeks, suggesting it as a viable additional treatment option.
June 2026 in “Vestnik dermatologii i venerologii” This study evaluated the use of Jet Peel technology, a non-invasive hydroporation method, in treating androgenetic and telogen effluvium alopecia, finding improvements in hair growth and thickness, and a reduction in associated scalp conditions.
January 2026 in “CyberLeninK (CyberLeninka)” In this study, researchers found that combining advanced physiotherapy and specialized dermacosmetics in patients with androgenetic alopecia significantly improved metabolic markers, increasing serum zinc, copper, folic acid, and vitamin D levels more than standard treatments.
July 2024 in “Russian Journal of Child Neurology” This study observed that among children with neurofibromatosis type 1 in Russia, selumetinib treatment led to a partial reduction in plexiform neurofibroma volume in 65% of cases, with 56% showing a long-term response without surgery; common side effects included skin rash and hair issues.
